These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8749627)

  • 1. Spectrum of parvovirus B19 infection: analysis of an outbreak of 43 cases in Cadiz, Spain.
    García-Tapia AM; Fernandez-Gutiérrez del Alamo C; Girón JA; Mira J; de la Rubia F; Martínez-Rodríguez A; Martín-Reina MV; López-Caparros R; Cáliz R; Caballero MS
    Clin Infect Dis; 1995 Dec; 21(6):1424-30. PubMed ID: 8749627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Observations on human parvovirus B19 infection diagnosed in 2011].
    Mihály I; Trethon A; Arányi Z; Lukács A; Kolozsi T; Prinz G; Marosi A; Lovas N; Dobner IS; Prinz G; Szalai Z; Pék T
    Orv Hetil; 2012 Dec; 153(49):1948-57. PubMed ID: 23204301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The frequency of human parvovirus B19 infections in Vojvodina].
    Milosević V; Jerant-Patić V; Hrnjaković-Cvjetković I; Vukmanović-Papuga M; Jelena RT; Kovacević G
    Med Pregl; 2007; 60(11-12):575-9. PubMed ID: 18666599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibodies against human parvovirus B19 in the Madrid community].
    de Ory F; Pachón I; Ramírez R; Echevarría JM
    Enferm Infecc Microbiol Clin; 1999; 17(7):364-5. PubMed ID: 10535193
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute human parvovirus B-19 infection in hospitalized children: A serologic and molecular survey.
    Miron D; Luder A; Horovitz Y; Izkovitz A; Shizgreen I; Ben David E; Ohnona FS; Schlesinger Y
    Pediatr Infect Dis J; 2006 Oct; 25(10):898-901. PubMed ID: 17006284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythema infectiosum and other parvovirus B19 infections.
    Kirchner JT
    Am Fam Physician; 1994 Aug; 50(2):335-41. PubMed ID: 8042568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of parvovirus B19 in aplastic crisis and erythema infectiosum (fifth disease).
    Chorba T; Coccia P; Holman RC; Tattersall P; Anderson LJ; Sudman J; Young NS; Kurczynski E; Saarinen UM; Moir R
    J Infect Dis; 1986 Sep; 154(3):383-93. PubMed ID: 3016109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human parvovirus B19 in Iranian pregnant women: a serologic survey.
    Khameneh ZR; Hanifian H; Barzegari R; Sepehrvand N
    Indian J Pathol Microbiol; 2014; 57(3):442-4. PubMed ID: 25118740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human parvovirus B19 infection and antiphospholipid antibodies.
    von Landenberg P; Lehmann HW; Modrow S
    Autoimmun Rev; 2007 Apr; 6(5):278-85. PubMed ID: 17412298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of parvovirus B19 specific antibody in pregnant women with spontaneous abortion.
    Rahbar N; Vali Zadeh S; Ghorbani R; Kheradmand P
    Acta Med Iran; 2015; 53(3):168-72. PubMed ID: 25796023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occupational risk of human parvovirus B19 infection for school and day-care personnel during an outbreak of erythema infectiosum.
    Gillespie SM; Cartter ML; Asch S; Rokos JB; Gary GW; Tsou CJ; Hall DB; Anderson LJ; Hurwitz ES
    JAMA; 1990 Apr; 263(15):2061-5. PubMed ID: 2157074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Seroprevalence of parvovirus B19 in our area and its distribution by ages and sexes].
    Güerri ML; Prior C; Merino R; Zapico R
    Enferm Infecc Microbiol Clin; 2000 May; 18(5):243-4. PubMed ID: 10974772
    [No Abstract]   [Full Text] [Related]  

  • 13. [Systemic manifestations of Parvovirus B19 infections].
    Sève P; Ferry T; Charhon A; Calvet A; Broussolle C
    Rev Med Interne; 2004 Oct; 25(10):740-51. PubMed ID: 15471600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An unusual outbreak of parvovirus B19 infections, France, 2023 to 2024.
    d'Humières C; Fouillet A; Verdurme L; Lakoussan SB; Gallien Y; Coignard C; Hervo M; Ebel A; Soares A; Visseaux B; Maire B; Juan PH; Parent du Châtelet I; Guthmann JP; Durand J
    Euro Surveill; 2024 Jun; 29(25):. PubMed ID: 38904112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Parvovirus B19 infection: the general aspects and gestational problems].
    Di Stefano L; Carta G; Barnabei R; Tomei E; Toro G; Moscarini M
    Minerva Ginecol; 1995 Apr; 47(4):121-5. PubMed ID: 7644092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Parvovirus B19 outbreak in a rural community in Alicante].
    Martínez-Campillo F; López J; Verdú M; Andreu M; Rigo MV
    Enferm Infecc Microbiol Clin; 2002 Oct; 20(8):376-9. PubMed ID: 12372232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical and biological manifestations in primary parvovirus B19 infection in immunocompetent adult: a retrospective study of 26 cases].
    Parra D; Mekki Y; Durieu I; Broussolle C; Sève P
    Rev Med Interne; 2014 May; 35(5):289-96. PubMed ID: 23773900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged parvovirus b19 viremia in spite of neutralizing antibodies after erythema infectiosum in pregnancy.
    Dobec M; Juchler A; Flaviano A; Kaeppeli F
    Gynecol Obstet Invest; 2007; 63(1):53-4. PubMed ID: 16940737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Infection with parvovirus B19: typical course of erythema infectiosum and its complications].
    Kirchesch H
    Z Hautkr; 1990 Nov; 65(11):1007-10. PubMed ID: 1964320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infections caused by parvovirus B19.
    Chinea B; Ramírez Ronda CH
    Bol Asoc Med P R; 1996; 88(1-3):20-6. PubMed ID: 8885443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.